|
GNG10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.244050E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.217600E-04 |
| Normal-vs-Stage2 |
1.503560E-02 |
| Normal-vs-Stage3 |
3.344500E-02 |
| Normal-vs-Stage4 |
7.211600E-01 |
| Stage1-vs-Stage2 |
8.689400E-01 |
| Stage1-vs-Stage3 |
4.267800E-01 |
| Stage1-vs-Stage4 |
2.478000E-03 |
| Stage2-vs-Stage3 |
5.274800E-01 |
| Stage2-vs-Stage4 |
1.312100E-02 |
| Stage3-vs-Stage4 |
3.144100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.023930E-02 |
| Normal-vs-AfricanAmerican |
3.038300E-03 |
| Normal-vs-Asian |
2.576000E-01 |
| Caucasian-vs-AfricanAmerican |
1.810200E-01 |
| Caucasian-vs-Asian |
3.362200E-01 |
| AfricanAmerican-vs-Asian |
5.330100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.948200E-02 |
| Normal-vs-Female |
6.209900E-04 |
| Male-vs-Female |
2.768000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.201500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.190100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.905800E-02 |
| Normal-vs-Age(81-100Yrs) |
9.874600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.266550E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.468960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.104200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.036400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.460000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.265000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.738000E-01 |
| Classical-VS-Follicular |
1.560400E-02 |
| Classical-VS-Other |
7.914000E-01 |
| Classical-VS-Normal |
7.217500E-03 |
| Tall-VS-Follicular |
1.870020E-02 |
| Tall-VS-Other |
5.478800E-01 |
| Tall-VS-Normal |
4.578800E-01 |
| Follicular-VS-Other |
5.483800E-01 |
| Follicular-VS-Normal |
2.554100E-04 |
| Other-VS-Normal |
1.689220E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.240100E-04 |
| Normal-vs-N1 |
7.605200E-01 |
| N0-vs-N1 |
4.360900E-03 |
|
|
